Skip to main content
Login
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

PureTech Forms Respiratory Spin-Off Celea to Advance Deuterated Pirfenidone

Summary by Pharmaceutical-technology.com
PureTech's latest spinoff Celea Therapeutics was created to progress the former's lead respiratory IPF programme, deupirfenidone.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

pharmaceutical-technology.compharmaceutical-technology.com

PureTech forms respiratory spin-off Celea to advance deuterated pirfenidone

PureTech's latest spinoff Celea Therapeutics was created to progress the former's lead respiratory IPF programme, deupirfenidone.

Read Full Article
GeneOnline NewsGeneOnline News

Sven Dethlefs Appointed to Lead PureTech Health’s New Respiratory Division Celea Focused on IPF Treatment

PureTech Health has appointed Sven Dethlefs, former CEO […] The post Sven Dethlefs Appointed to Lead PureTech Health’s New Respiratory Division Celea Focused on IPF Treatment first appeared on GeneOnline News. The post Sven Dethlefs Appointed to Lead PureTech Health’s New Respiratory Division Celea Focused on IPF Treatment appeared first on GeneOnline News.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

GeneOnline News broke the news in on Wednesday, August 13, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

News
For You
SearchBlindspotLocal